Motor function and human immunodeficiency virus-associated cognitive impairment in a highly active antiretroviral therapy-era cohort

Archives of Neurology

Volumn 65, Issue 8, 2008, Pages 1096-1101

  Robinson Papp, Jessica ^a   Byrd, Desiree ^a   Mindt, Monica Rivera ^a   Oden, Neal Leonard ^b   Simpson, David M ^a   Morgello, Susan ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b EMMES CORPORATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYSIS OF VARIANCE; APATHY; ARTICLE; BECK DEPRESSION INVENTORY; BEHAVIOR DISORDER; COGNITION; COGNITIVE DEFECT; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GLOBAL NEUROPSYCHOLOGICAL T SCORE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED DEMENTIA; HUMAN IMMUNODEFICIENCY VIRUS ASSOCIATED DEMENTIA MOTOR SCALE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LINEAR REGRESSION ANALYSIS; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; RATING SCALE;

ADULT; AIDS DEMENTIA COMPLEX; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COGNITION DISORDERS; COHORT STUDIES; FEMALE; HIV; HIV INFECTIONS; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOTOR SKILLS; MOTOR SKILLS DISORDERS; NEUROPSYCHOLOGICAL TESTS;

EID: 49449114805     PISSN: 00039942     EISSN: 15383687     Source Type: Journal    
DOI: 10.1001/archneur.65.8.1096     Document Type: Article

References (19)

1. Navia BA, Jordan B, Price R. The AIDS dementia complex, I: clinical features. Ann Neurol. 1986;19(6):517-524.
2. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection: report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology. 1991;41(6):778-785.
3. Tozzi V, Balestra P, Bellagamba R, et al. Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIVrelated neurocognitive impairment. J Acquir Immune Defic Syndr. 2007;45 (2):174-182.
4. Brew BJ, Pemberton L, Cunningham P, Law MG. Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage. J Infect Dis. 1997;175(4):963-966.
5. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol. 1997;42(5):689-698.
6. McArthur JC, McDermott MP, McClernon D, et al. Attenuated central nervous system infection in advanced HIV/AIDS with combination antiretroviral therapy. Arch Neurol. 2004;61(11):1687-1696.
7. Dean HD, Steele CB, Satcher AJ, Nakashima AK. HIV/AIDS among minority races and ethnicities in the United States, 1999-2003. J Natl Med Assoc. 2005;97 (7)(suppl):5S-12S.
8. Antinori A, Arendt G, Becker JT, et al. Updated research nosology for HIV-associated neurocognitive disorders. Neurology. 2007;69(18):1789- 1799.
9. Morgello S, Estanislao L, Simpson D, et al. HIV-associated distal sensory polyneuropathy in the era of highly active antiretroviral therapy: the Manhattan HIV Brain Bank. Arch Neurol. 2004;61(4):546-551.
10. Ryan EL, Morgello S, Isaacs K, Naseer M, Gerits P; The Manhattan HIV Brain Bank. Neuropsychiatric impact of hepatitis C on advanced HIV. Neurology. 2004;62(6):957-962.
11. Carey CL, Woods SP, Rippeth JD, et al. Initial validation of a screening battery for the detection of HIV-associated cognitive impairment. Clin Neuropsychol. 2004;18(2):234-248.
12. Woods SP, Rippeth JD, Frol AB, et al. Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. J Clin Exp Neuropsychol. 2004;26(6):759-778.
13. Beck AT, Beamesderfer A. Assessment of depression: the depression inventory. Mod Probl Pharmacopsychiatry. 1974;7(0):151-169.
14. Hasin DS, Trautman KD, Miele GM, Samet S, Smith M, Endicott J. Psychiatric Research Interview for Substance and Mental Disorders (PRISM): reliability for substance abusers. Am J Psychiatry. 1996;153(9):1195- 1201.
15. Fahn S, Elton R; Members of the UPDRS Development Committee. Unified Parkinson's disease rating scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent Developments in Parkinson's Disease. Vol 2. Florham Park, NJ: Macmillan Health Care Information; 1987:153-163, 293-304.
16. Wilkinson G. Wide Range Achievement Test, 3rd Edition: Administration Manual. Wilmington, DE: Wide Range Inc; 1993.
17. Nunnally JC, Bernstein IH. Psychometric Theory. New York, NY: McGraw-Hill Inc; 1994.
18. Ryan EL, Baird R, Mindt MR, et al. Neuropsychological impairment in racial/ethnic minorities with HIV infection and low literacy levels: effects of education and reading level in participant characterization. J Int Neuropsychol Soc. 2005;11(7):889-898.
19. von Giesen HJ, Haslinger BA, Rohe S, Köller H, Arendt G. HIV Dementia Scale and psychomotor slowing: the best methods in screening for neuro-AIDS. J Neuropsychiatry Clin Neurosci. 2005;17(2):185-191.